Cognetivity Neurosciences Ltd

#CognICA Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service #NHS: mailchi.mp/cognetivity.co… @FrontPubHealth

Our Latest PeerReviewed Study Highlights Cost-Efficiency and Improved Clinical Outcomes From Using #CognICA, Showing Savings of Over £40 Million Per Year Compared With Traditional #CognitiveAssessment Tools in Primary and Secondary Care. frontiersin.org/articles/10.33… #HealthEconomics

Today marks #WorldAlzheimersDay. We’re proud of our partner @Cognetivity who are making major advancements in the #dementia detection space. Learn more about our partnership: intersystems.com/uk/success-sto…

📣 Exciting Partnership Announcement on World Alzheimer's Day! Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology finance.yahoo.com/news/cognetivi… #WorldAlzheimersDay #Cognetivity #NoFearCounselling

Thrilled to announce that we've won the prestigious #CogX2023 Award for Best AI Product in Health! A big shoutout to our incredible team at @Cognetivity. The future of #Alzheimers care is here and now. Let's connect and make an impact together! 🌟🧠🏆 #HealthTech #AI #Innovation

Excited to share our latest Publication! We explored how the Integrated Cognitive Assessment (ICA) can improve primary care referrals to memory services. 🧠 *ICA had Sensitivity of 93% for dementia *Reduced unnecessary GP referrals by ~72% frontiersin.org/articles/10.33… @Cognetivity

New Disease Modifying Drug for Alzheimer’s Disease Approved by FDA, Crucial Role for Cognetivity - mailchi.mp/cognetivity.co…

Cognetivity Update June 2023 - mailchi.mp/cognetivity.co…

This is a great opportunity to enhance the benefits of early intervention and personalized care, ultimately promoting brain health, well-being, and improved quality of life. #CognetivityNeurosciences #CognICA #Alzheimers #Lecanemab cognetivity.com/cognetivity_to…

Following the approval of Leqembi, a breakthrough drug to treat Alzheimer's, our AI technology is positioned to provide crucial real-world evidence for the drug's effectiveness. As a result, our technology is well-positioned to provide the necessary basis for reimbursement by CMS

Cognetivity Partners with Clairvo to Advance AI Powered Brain Health Management in Japan - mailchi.mp/cognetivity.co…

Cognetivity to Play Pivotal Role in Delivery of New Alzheimer's Drugs - mailchi.mp/cognetivity.co…

Cognetivity Announces Collaboration with Alzheimer's Society - mailchi.mp/cognetivity.co…

Eli Lilly releases positive results on latest drug for Alzheimer’s disease - mailchi.mp/cognetivity.co…

Eli Lilly releases positive results on latest drug for Alzheimer’s disease - mailchi.mp/cognetivity.co…

Cognetivity Neurosciences Announces Agreement With Japanese Life Insurance Company - mailchi.mp/cognetivity.co…

Cognetivity Neurosciences Appoints Renowned Life Sciences Leader - mailchi.mp/cognetivity.co…

Cognetivity Unveils Groundbreaking Research on Cognition and Sleep - Extends Collaboration with University of Oxford - mailchi.mp/cognetivity.co…

Cognetivity Enters Commercial Agreement with UK-Based Brain Health Supplements Provider - mailchi.mp/cognetivity.co…

Cognetivity Publishes Outstanding Results & Expands Deployment With Senior Care Network in Singapore - mailchi.mp/cognetivity.co…